authorandyear,gmfcs,wppsi_iii,wisc_iv,bayley_ii_cognitive,bayley_iii_cognitive,bayley_iii_language,bayley_ii_cognitive_p_value,bayley_iii_cognitive_p_value,bayley_iii_language_p_value,definition,time_window,significance,geographic_origin,treatment,sample_size
"Ambalavanan et al., 2006",Gross motor function was graded according to the GMFCS with levels from 1 to 5.,,,-1.0,-1.0,-1.0,-1.0,-1.0,-1.0,"Death or moderate/severe disability assessed by mental development index score, GMFCS grade, hearing or vision impairment, or persistent seizure disorder.",18 to 22 months after birth,51% experienced death or disability,United States,Hypothermia,205.0
"Laptook et al., 2009","Level 3 to 5 indicates severe disability, Level 2 indicates moderate disability.",,,70.0,-1.0,-1.0,-1.0,-1.0,-1.0,Death or moderate/severe disability at 18 to 22 months of age.,18 to 22 months of age.,Each point decrease in Apgar score at 10 minutes was associated with a 45% increase in the odds of death or disability.,United States,Whole-body hypothermia,208.0
"Natarajan G, et al. 2013","The GMFCS was used to categorize the severity of CP (levels I-V), with severe disability being level IV or V and moderate disability being level III","The WPPSI-III for children below 7 years and 3 months was used to evaluate verbal, performance, and full scale IQ","For older children, the WISC-IV was used for evaluation",-1.0,-1.0,-1.0,-1.0,-1.0,-1.0,Death or moderate/severe disability at 6–7 years of age.,6–7 years,Each point increase in 10 min Apgar scores was associated with a significantly lower risk of death/disability (p<0.05).,USA,Whole body cooling,174.0
Perez JMR et al. Rev Assoc Med Bras 2017,N/A,N/A,N/A,-1.0,-1.0,-1.0,-1.0,-1.0,-1.0,"The study does not specify a single primary outcome but focuses on the development and validation of a simple clinical neurological score for the early diagnosis and management of hypoxic-ischemic encephalopathy (HIE) in newborns, which involves assessing ten clinical aspects for diagnosis and management guidance.","The score is to be used from the delivery room onwards, beginning as soon as the Apgar score is completed and for continuous evaluation over the first hours and days of life.","The study aims to facilitate early diagnosis and appropriate therapeutic measures, such as therapeutic hypothermia, by using a simple, easily implemented clinical score from the Iberoamerican Society of Neonatology (Siben) to improve outcomes for newborns with hypoxic-ischemic encephalopathy, especially in resource-limited settings.",Brazil,Therapeutic hypothermia,26.0
